Open-label Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Auriхim

NCT03057418 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, Follicular

Interventions

DRUG: Aurixim

Sponsor

Biointegrator LLC